14 September 2018
Can a Novel High-Density EEG Approach Disentangle the Differences of Visual Event Related Potential (N170) in People with Subjective Cognitive Impairment?
Greek researchers investigated whether specific brain regions, which have been found to be highly activated after negative facial stimulus, are also activated in different groups of people with subjective cognitive impairment (SCI), mild cognitive impairment (MCI) and Alzheimer’s Disease (AD) compared to healthy controls (HC).
1 September 2018
Every year in September across the globe, efforts are made to increase awareness of AD and dementia – and the ongoing research into the disease – during World Alzheimer's Month. Join our commmunity in spreading awareness of the impact JAD has, and what our journal achieves in terms of advancing knowledge in the field, and you could be enter a draw to win a copy of our latest book! Read more
23 August 2018
To keep our JAD editors, authors, and readers informed of JAD's progress and development, the journal hereby shares the 2018 editorial update.
21 August 2018
In the largest known brain imaging study, scientists from Amen Clinics (Costa Mesa, CA), Google, John’s Hopkins University, University of California, Los Angeles and the University of California, San Francisco evaluated 62,454 brain SPECT (single photon emission computed tomography) scans of more than 30,000 individuals from 9 months old to 105 years of age to investigate factors that accelerate brain aging. SPECT tomography) evaluates regional cerebral blood flow in the brain that is reduced in various disorders.
20 August 2018
Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany
Osteoporosis is estimated to affect 200 million women across the world. In Germany, the prevalence of this chronic disease among people aged 50 years and older is around 15%. In recent decades, several authors have analyzed the impact of osteoporosis on the risk of cognitive decline, but, most of these studies have been conducted outside Europe. The goal of the present study was to investigate the impact of osteoporosis on the risk of developing dementia in almost 60,000 patients followed for up to 20 years in more than 1,200 general practices in Germany.
26 July 2018
Driving is a complex task that involves perceptual, motor and cognitive abilities. These abilities may be affected in early Alzheimer Disease (AD) patients. Nevertheless, they continue to drive for more years than people with other dementia syndromes perhaps because of a deficit in self-awareness that prevents them from perceiving their driving difficulties and adapting accordingly. The purpose of the present pilot study was to closely examine the self-regulation behavior of older individuals with AD using a naturalistic driving approach.
16 July 2018
The celebration of JAD's 20th celebration continues this month with not one but two new publications. At AAIC 2018 in Chicago, will be presenting a special edition commemorative publication for JAD's 20th anniversary that looks back, as well as forward, to the journey that lies ahead for AD research. Discover the milestones that have led to JAD becoming a vehicle for more papers on AD than any other journal, receiving more citations than any other AD-focused journal. Read on for more details.
16 July 2018
JAD is pleased to announce that Greg Kennedy, a PhD candidate at the Centre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, Australia, has been chosen as the recipient of the 2018 Alzheimer Award.
20 June 2018
Ground-breaking new research has identified a unique combination of nutrients to slow the progression of Alzheimer’s Disease (AD), which affects over 520,000 people in the UK and represents a burden on the struggling NHS of over £26 billion per year. The 18-month study, published in the June edition of the respected Journal of Alzheimer’s Disease (JAD), examined the effect of nutritional compounds - found in common foods such as trout, broccoli, and peppers on people with the condition, and unveiled a ‘statistically significant’ find.
19 June 2018
An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix (DBS-f), as observed in the data from the phase 2 findings (12 – 24 months) of the Phase II trial.